Drug Approvals | eHealth News | Page 32

Xalkori (crizotinib) has been approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer with tumors that have a rare ROS1 gene mutation.

FDA Approves Xalkori for Rare Genetic Form of Lung Cancer

HealthDay.com - Mar 11, 2016 0

Drug approval expanded to include patients with ROS1-positive NSCLC

Briviact (brivaracetam) has been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 16 and older with epilepsy.

FDA Approves Briviact for Partial Onset Seizures

HealthDay.com - Feb 19, 2016 0

Drug sanctioned for epilepsy patients aged 16 and older

Zepatier (elbasvir and grazoprevir) has been approved by the U.S. Food and Drug Administration to treat chronic hepatitis C virus genotypes 1 and 4 infections.

FDA Approves Zepatier for Chronic Hepatitis C

HealthDay.com - Jan 29, 2016 0

Medication indicated for patients with hepatitis C virus genotypes 1 and 4 infections

Halaven (eribulin mesylate) has been approved by the U.S. Food and Drug Administration as the first chemotherapy drug shown to improve survival in people with advanced liposarcoma.

FDA Approves Halaven for Advanced Liposarcoma

HealthDay.com - Jan 28, 2016 0

FDA says it's first liposarcoma drug to improve survival

The Integra Omnigraft Dermal Regeneration Matrix has been approved by the U.S. Food and Drug Administration to treat diabetic foot ulcers.

FDA Approves Device for Diabetic Foot Ulcers

HealthDay.com - Jan 8, 2016 0

The device, first approved to treat burns, is made of silicone, cow collagen, and shark cartilage

Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.

FDA Approves Zurampic for the Treatment of Gout

HealthDay.com - Dec 23, 2015 0

Drug helps control blood levels of uric acid

Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension.

FDA Approves Uptravi for Pulmonary Arterial Hypertension

HealthDay.com - Dec 22, 2015 0

Drug found to limit worsening of the disease and reduce the need for hospitalization

The Fenix Continence Restoration System has been approved by the U.S. Food and Drug Administration to treat an inability to control bowel movements for patients who can't tolerate or use other approved methods.

FDA Approves New Device for Fecal Incontinence

HealthDay.com - Dec 18, 2015 0

Viable surgical option when medical measures have failed

The LifeVest wearable defibrillator has been approved by the U.S. Food and Drug Administration for children at risk for cardiac arrest who can't have a defibrillator implanted. The device is already approved for adults.

FDA Approves LifeVest Wearable Defibrillator for Children

HealthDay.com - Dec 17, 2015 0

For heart patients who can't have device implanted

Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide.

FDA Approves Bridion to Reverse Neuromuscular Blockade

HealthDay.com - Dec 16, 2015 0

Drug reverses the effects of rocuronium bromide and vecuronium bromide

1...313233...40 Page 32 of 40

Archives